ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68 Ga-labelled cyclic peptides tracers: from bench to bedside
Journal for ImmunoTherapy of Cancer · 2024-07 · 12 (7) · e009153
DOI: 10.1136/jitc-2024-009153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 25.07.2024. Verfasst von Ming Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Lymphocyte Activation Gene 3 Protein, Peptides, Cyclic, Gallium Radioisotopes, Tumor Microenvironment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of CPSF, Science and Technology Innovation Program of Hunan Province.
Abstract (Originalsprache)
Background
Lymphocyte activation gene 3 (LAG-3) has been considered as the next generation of immune checkpoint and a promising prognostic biomarker of immunotherapy. As with programmed cell death protein-1/programmed death-ligand 1 and cytotoxic T-lymphocyte antigen-4 inhibitors, positron emission tomography (PET) imaging strategies could benefit the development of clinical decision-making of LAG-3-related therapy. In this study, we developed and validated 68 Ga-labeled cyclic peptides tracers for PET imaging of LAG-3 expression in bench-to-bedside studies.
Methods
A series of LAG-3-targeted cyclic peptides were modified and radiolabeled with 68 GaCl 3 and evaluated their affinity and specificity, biodistribution, pharmacokinetics, and radiation dosimetry in vitro and in vivo. Furthermore, hu-PBL-SCID (PBL) mice models were constructed to validate the capacity of [ 68 Ga]Ga-CC09-1 for mapping of LAG-3 + lymphocytes infiltrates using longitudinal PET imaging. Lastly, [ 68 Ga]Ga-CC09-1 was translated into the first-in-human studies to assess its safety, biodistribution and potential for imaging of LAG-3 expression.
Results
A series of cyclic peptides targeting LAG-3 were employed as lead compounds to design and develop 68 Ga-labeled PET tracers. In vitro binding assays showed higher affinity and specificity of [ 68 Ga]Ga-CC09-1 in Chinese hamster ovary-human LAG-3 cells and peripheral blood mononuclear cells. In vivo PET imaging demonstrated better imaging capacity of [ 68 Ga]Ga-CC09-1 with a higher tumor uptake of 1.35±0.33 per cent injected dose per gram and tumor-to-muscle ratio of 17.18±3.20 at 60 min post-injection. Furthermore, [ 68 Ga]Ga-CC09-1 could detect the LAG-3 + lymphocyte infiltrates in spleen, lung and salivary gland of PBL mice. In patients with melanoma and non-small cell lung cancer, primary lesions with modest tumor uptake were observed in [ 68 Ga]Ga-CC09-1 PET, as compared with that of [ 18 F]FDG PET. More importantly, [ 68 Ga]Ga-CC09-1 delineated the heterogeneity of LAG-3 expression within large tumors.
Conclusion
These findings consolidated that [ 68 Ga]Ga-CC09-1 is a promising PET tracer for quantifying the LAG-3 expression in tumor microenvironment, indicating its potential as a companion diagnostic for patients stratification and therapeutic response monitoring in anti-LAG-3 therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Key Laboratory of Biological Nanotechnology of National Health Commission, Changsha, Hunan, China.
- Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China hushuo2018@163.com xbwan…
- Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China hushuo2018@163.com xbwang1109@hotmail.com.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Shuo Hu
Förderung
- National Natural Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- Science and Technology Innovation Program of Hunan Province
- Key Program of Ministry of Industry and Information Technology of China
- Hunan Provincial Health High-Level Talent Scientific Research Project
- Natural Science Foundation of Hunan Province of China
Zitieren
APA
Zhou, M., Chen, B., Lu, C., Yang, J., Liu, P., Wang, X., & Hu, S. (2024). ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68 Ga-labelled cyclic peptides tracers: from bench to bedside. Journal for ImmunoTherapy of Cancer, 12(7), e009153. https://doi.org/10.1136/jitc-2024-009153
Vancouver
Zhou M, Chen B, Lu C, Yang J, Liu P, Wang X, et al. ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68 Ga-labelled cyclic peptides tracers: from bench to bedside. Journal for ImmunoTherapy of Cancer. 2024;12(7):e009153. doi:10.1136/jitc-2024-009153
BibTeX
@article{Zhou2024,
author = {Zhou, Ming and Chen, Bei and Lu, Chenxi and Yang, Jinhui and Liu, Peng and Wang, Xiaobo and Hu, Shuo},
title = {ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68 Ga-labelled cyclic peptides tracers: from bench to bedside},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {7},
pages = {e009153},
doi = {10.1136/jitc-2024-009153}
}
EUVIMED